| Table 2. Characterization of the group of volunteers who received vaccination against COVID-19 and underwent AMH measurement. | ||
| Variáveis | Median (p25 - 75) | Average (sd) |
|---|---|---|
| Age (years) | 24 (22 - 30) | 25.9 (5.38) |
| Menarche (years) | 12 (11 - 13) | 11.68 (1.34) |
| Menstrual cycle length (days) | 4 (3 - 4) | 3.66 (0.85) |
| Menstrual cycle interval (days) | 28 (26-30) | 28.63 (3.49) |
| n | % | |
| Comorbidities No Yes |
33 5 |
86.84 13.16 |
| Previus surgical No Yes |
27 11 |
71.05 28.95 |
| Contraceptive method No COC* Quarterly injectable IUD† Cooper |
6 18 3 11 |
15.79 47.37 7.89 28.95 |
| Parity 0 1 2 |
35 2 1 |
92.11 5.26 2.63 |
| Number of cesarean sections 0 1 2 |
37 0 1 |
97.37 0 2.63 |
| Number of abortions 0 1 |
36 2 |
94.74 5.26 |
| Number of children 0 1 2 |
37 0 1 |
97.37 0 2.63 |
| Smoking No Yes |
37 1 |
97.37 2.63 |
| Alcoholism No Yes |
38 0 |
100 0 |
| Drug addiction No Yes |
38 0 |
100 0 |
| Exposure to SARS-CoV-2‡ No (NEXP) § Yes (EXP) || |
30 8 |
78.95 21.05 |
*COC: combined oral contraceptive.
†IUD: copper intrauterine device.
‡SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.
§NEXP: not exposed.
||EXP: exposed.